Treatment for Inflammatory Bowel Diseases
This study is evaluating whether fecal transplantation is safe and effective for treating recurrent C. Difficile in children.
See full descriptionAbout the trial for Inflammatory Bowel Diseases
Treatment Groups
This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex aged 65 and younger. You must have received 1 prior treatment for Inflammatory Bowel Diseases or one of the other 6 conditions listed above. There are 6 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Inflammatory Bowel Diseases. Measurement will happen over the course of 7 days.
Patient Q & A Section
How many people get inflammatory bowel diseases a year in the United States?
Most of the people who get an inflammatory bowel disease encounter it between the ages of 18 and 50. The disease is more common in women than men and in whites than minorities. Power makes it easy to find IBD clinical trials tailored to your condition, type of disease, and location.
What are the signs of inflammatory bowel diseases?
If patients presenting with unexplained IBD symptoms present with signs of diarrhea or a change in bowel habit, they may have intestinal tuberculosis. Other signs of IBD include abdominal pain, constipation, unexplained weight loss or malaise. IBD is a type of inflammatory bowel disease.\n
What is inflammatory bowel diseases?
IBD can present as an inflammatory and autoimmune disorder that has numerous presentations. IBD often begins in childhood and continues on through a person's life. It is important for a person's doctor to know what presentations and presentations, if any, the patient might display.\n
What are common treatments for inflammatory bowel diseases?
Crohn's disease and ulcerative colitis are both treated with antibiotics and are most often symptomatic, but often require surgery. The number of IBD patients and their families are growing every day. It is important to be aware of all options and to discuss the possibility for all patients to be involved in decisions about treating their IBD.
What causes inflammatory bowel diseases?
Many autoimmune illnesses, allergies, and certain environmental factors may cause inflammatory bowel diseases. They are a group of painful intestinal disorders, which include chronic colitis, Crohn's disease, or ulcerative colitis, and they are associated with an increased risk of early death from colorectal cancer.
Can inflammatory bowel diseases be cured?
Patients with IBD have a high mortality because of the complications of the disease. With careful care, most patients can maintain normal lives without any sign of the disease, with only a few having minor symptoms.
What are the common side effects of treatment?
Treatment of ulcerative colitis and Crohn's disease can be challenging due to the high probability of serious disease flares and the relatively unbalanced nature of long-term treatment. Although severe side effects occur infrequently, the side effects encountered should be considered when treatment decisions are made.\n
What does treatment usually treat?
There is now an opportunity to exploit the high prevalence of inflammatory bowel disease among people who live on remote islands and to provide evidence-based treatment approaches to manage these diseases at all stages of life.
What is treatment?
A treatment protocol for question: Is question: Is patient reported outcome measures an accurate measure of satisfaction after gastrostomy insertion? answer: Patient reported and nurse observed satisfaction data may not be interchangeable. This implies that gastrostomies cannot replace quality of life measures in the assessment of GI patient satisfaction in standard clinical practice. However, gastrostomy should be considered an adjunct to the clinical assessment of patients with gastrointestinal conditions.
Have there been any new discoveries for treating inflammatory bowel diseases?
There has been some new discoveries for treating inflammatory bowel disease. However, the use of immunosuppressants and immunosuppressive drugs are not devoid of unwanted side effects and patients should be advised in the best way to manage their symptoms. The number of therapeutic options for treating inflammatory bowel disease is limited.
Has treatment proven to be more effective than a placebo?
As of today, the results from placebo-controlled trials and meta-analyses of placebo-controlled trials provide evidence that placebo is more effective than no treatment for several types of inflammatory bowel diseases.
What is the latest research for inflammatory bowel diseases?
The use of innovative ways to detect and treat IBD is growing rapidly and many exciting results have come from research underway from across the IBD and other areas of medicine. This rapid acceleration of discovery will ultimately lead to further improvements in the lives of patients.